NCT06499181View on ClinicalTrials.gov

Multimodal Orthognathic Study Comparing Use of Exparel With Standard of Care.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Pain, Postoperative
Interventions
DRUG

Liposomal bupivacaine

The primary objective is to examine differences in post-operative opioid consumption between the two groups.

DRUG

Bupivacain

Control group to receive 10cc of 0.5% bupivacaine with 1:50,000 epinephrine at the completion of the procedure per typical standard of care.

DRUG

Epinephrin

Control group to receive 10cc of 0.5% bupivacaine with 1:50,000 epinephrine at the completion of the procedure per typical standard of care.

Trial Locations (1)

92134

Naval Medical Center San Diego, San Diego

All Listed Sponsors
lead

United States Naval Medical Center, San Diego

FED

NCT06499181 - Multimodal Orthognathic Study Comparing Use of Exparel With Standard of Care. | Biotech Hunter | Biotech Hunter